Astrana Health Inc. (ASTH) Stock Analysis

Astrana Health coordinated value-based care for approximately 1.6 million patients through a network of more than 20,000 contracted physicians and over 60 Care Delivery locations, including primary care clinics, specialty clinics, and an acute-care hospital, as of December 31, 2025. The company derives a substantial portion of its revenue from California and, on July 1, 2025, completed its $674.9 million acquisition of Prospect Medical Holdings' businesses, adding an 11,000-provider network, a California Knox-Keene-licensed health plan, and a second acute-care hospital.

Astrana earns revenue primarily through capitation payments from HMOs and Medicare Advantage plans, under which its independent practice associations and Restricted Knox-Keene-licensed health plans accept a fixed per-member-per-month fee and assume the financial risk for medical costs above that amount, supplemented by risk-pool settlements and incentives, management fee income from its MSO subsidiaries under long-term management services agreements, and fee-for-service revenue. Because California's corporate-practice-of-medicine laws bar Astrana from directly owning physician practices, the company structures its affiliated IPAs and medical groups as physician-owned entities consolidated as variable interest entities, governed through MSAs and, in some cases, nominee-shareholder arrangements for professional corporations. Astrana's ACOs participate in CMS's ACO REACH Model and the Medicare Shared Savings Program, layering government-program risk-sharing on top of its commercial and Medicaid HMO capitation book, while its equity-method investments, ranging from 25.0% to 51.0% ownership in similarly structured healthcare entities, extend its platform beyond wholly consolidated operations.